Reuters logo
Valeant in talks to sell eye surgical products business - Bbg
June 6, 2017 / 1:21 PM / in 6 months

Valeant in talks to sell eye surgical products business - Bbg

June 6 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc is in talks to sell its Bausch & Lomb unit’s surgical products business to Germany’s Carl Zeiss Meditec AG, Bloomberg reported.

Valeant's eye-surgery assets may be valued at about $2 billion in a sale, Bloomberg reported, citing people familiar with the matter. (bloom.bg/2sckufc)

Valeant and Carl Zeiss were not immediately available for comment. (Reporting by Ahmed Farhatha in Bengaluru; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below